Nursing care
Somogyi Effect, explained for the bedside and the exam
Written and reviewed by Dana Whitfield, RN, MSN · 4 min read · Updated September 2026
Short answer
The Somogyi effect is a rebound high blood glucose in the morning, caused by an episode of hypoglycaemia overnight that triggers counter-regulatory hormones. The nursing response is counterintuitive: reduce the evening insulin dose rather than increase the morning one. Confirming it requires a 2-3am glucose check to catch the low before the rebound masks it.
What the concept actually says
The Somogyi effect describes a sequence, not a single reading. Insulin given too late in the evening, or dosed too high relative to the patient's overnight needs, drives blood glucose down while they sleep. The body responds to that hypoglycaemia by releasing cortisol, glucagon, epinephrine and growth hormone. These counter-regulatory hormones push glucose stores out of the liver, and by the time the patient wakes for a fasting check, the reading is high.
The trap is that the morning number looks like undertreatment. A nurse or a patient seeing an 11 mmol/L fasting glucose reads it as 'not enough insulin last night' and is tempted to increase the dose. That response makes the underlying hypoglycaemia worse the following night, and the rebound repeats. The name comes from Michael Somogyi, who first described this pattern in insulin-treated diabetes in the 1930s.
The clinical reasoning behind it
The physiology is a stress response, not a dosing failure. Counter-regulatory hormones exist to protect the brain from glucose starvation, and they overshoot. Hepatic glycogenolysis and gluconeogenesis are both switched on hard, and insulin sensitivity itself drops for several hours afterward, so the rebound glucose can sit high well past breakfast.
This is why the fasting glucose alone cannot confirm the Somogyi effect. A single high morning reading is also consistent with simple insulin under-dosing, or with the dawn phenomenon. What separates Somogyi is evidence of a low somewhere in the middle of the night: night sweats, restless sleep, nightmares, or a headache on waking are all clues worth asking about, but the reliable evidence is a glucose check between 2am and 4am.
Applying it under time pressure
At the bedside, the practical move is to check a 3am glucose before changing anything. If that reading is low or borderline low, the pattern fits Somogyi and the intervention is to reduce the evening intermediate or long-acting insulin dose, or shift its timing earlier, rather than adding more insulin at breakfast.
On an exam, the same logic applies to word choice. If a question describes hypoglycaemic symptoms overnight (diaphoresis, tremor, confusion reported by a caregiver) followed by a high fasting glucose, the correct action is a dose reduction, not an increase. Questions testing this concept are testing whether you will follow the reflex of 'high number, more insulin' or stop and ask what happened overnight first.
Common misconceptions
The most common error is treating every high fasting glucose as an insulin-deficiency problem. Increasing the bedtime dose in response to a Somogyi pattern deepens the nocturnal hypoglycaemia and can escalate to a dangerous low, particularly in patients with hypoglycaemia unawareness.
A second error is confusing Somogyi with the dawn phenomenon, which produces a similar morning high glucose through an entirely different mechanism, overnight growth hormone and cortisol release without a preceding low, and which is corrected by adjusting insulin upward, not down. The two are frequently paired in NCLEX-style items precisely because the correction is opposite. See dawn-phenomenon-nursing-guide for the mirror-image case.
Practice scenarios
A patient with type 1 diabetes on NPH insulin at dinner reports vivid dreams and a damp pillow most nights. Their 7am fasting glucose reads 13 mmol/L. The nursing priority is not to increase the dinner NPH dose; it is to schedule a 3am glucose check and review the evening dose and timing with the prescriber.
A second scenario: an older adult on a basal-bolus regimen has a fasting glucose of 12 mmol/L three mornings running. Their partner mentions the patient seemed confused and sweaty around 2am on one occasion. That single detail is the differentiator, it points toward Somogyi rather than dawn phenomenon, and it should prompt a nocturnal glucose check before any dose change.
Key takeaways
The Somogyi effect is rebound hyperglycaemia driven by an unrecognised nocturnal low, and the fix runs against instinct, less evening insulin, not more. Confirm the pattern with a middle-of-the-night glucose check rather than acting on the fasting number alone, and always rule out the dawn phenomenon before changing a dose in either direction.
The next step on this is the same as on everything else here: answer questions and read the rationales. Our endocrine practice questions are the closest set to what this page covers.
Common questions
What time should I check glucose to confirm the Somogyi effect?
Between 2am and 4am, timed to fall during the period of peak action for the patient's evening insulin. A low or borderline reading at that point, followed by a high fasting glucose, confirms the rebound pattern.
Is the Somogyi effect the same as the dawn phenomenon?
No. Both produce a high fasting glucose, but Somogyi follows a nocturnal low and is corrected by reducing evening insulin, while the dawn phenomenon has no preceding low and is corrected by increasing it. Mixing the two up is the most common error on questions testing this content.
Why would an NCLEX question describe night sweats before asking about morning glucose?
Night sweats, restless sleep, or a reported nightmare are the clinical clues pointing to an overnight hypoglycaemic episode. The question is testing whether you connect that detail to a rebound high rather than reading the fasting glucose in isolation.
Does the Somogyi effect happen with insulin pumps?
It can, though continuous basal delivery makes large overnight lows less common than with a single evening dose of intermediate-acting insulin. Continuous glucose monitoring has made the pattern easier to catch in real time rather than inferring it from a fasting reading.
What should I chart if I suspect the Somogyi effect?
Document the fasting glucose, any reported overnight symptoms, the results of a nocturnal glucose check if one was obtained, and communicate the suspected pattern to the prescriber before any insulin dose is adjusted.